Abstract:
World Trade Organization (WTO) is now relevant for signatories. India being one of the initial signatories
need to ensure that product patent concerning pharmaceutical industry is considered seriously. Even though
it was clear that Indian companies are not investing in the Research and Development (R&D) activities, it
was pertinent to understand the magnitude of the same from the managers themselves. This study was conducted
through a questionnaire, which was circulated among the 400 registrants of the Indian Drug Manufacturers
Association (IDMA). However, there were only 231 responses. Inferential statistics, descriptive calculations,
Klomogrov- Simrnov test, discriminant function analysis were used for the analysis. Considering
the importance attached to the variables, the study revealed very important findings which were provided in
the article as suggestions. Now all the major Indian companies have started realizing the importance of new
product development and R&D.
